http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-045819-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a910d33c239980f3a705e312c5bad6a
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D235-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D235-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D235-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4184
filingDate 2004-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2005-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AR-045819-A1
titleOfInvention DERIVATIVES OF BENZIMIDAZOL COMPOSITIONS THAT CONTAIN THEM, PREPARATION OF THE SAME AND USES OF THE SAME
abstract This refers to compounds that are useful in therapy, in particular for the treatment of pain. Claim 1: A compound of formula (1) or a pharmaceutically acceptable salt thereof, wherein: R1 is selected from C1-10 alkyl, C2-10 alkenyl, C2-10 alkynyl, R5R6N-C1-6 alkyl, R5O- C1-6 alkyl, R5C (= O) N (-R6) -C1-6 alkyl, R5R6NS (= O) 2-C1-6 alkyl, R5CS (= O) 2N (-R6) -C1-6 alkyl, R5R6NC (= O) N (-R7) -C1-6 alkyl, R5R6NS (= O) 2N (R7) -C1-6 alkyl, aryl (C6-10) - alkyl (C1-6), aryl (C6-10) -C (= O) -C1-6 alkyl, (C3-10) cycloalkyl-(C1-6) alkyl, (C4-8) cycloalkenyl-(C1-6) alkyl, heterocyclyl (C3-6) -alkyl (C1 -6), heterocyclyl (C3-6) -C (= O) -C1-6 alkyl, C1-10 hydrocarbylamino, R5R6N-, R5O-, R5C (= O) N (-R6) -, R5R6NS (= O) 2-, R5CS (= O) 2N (-R6) -, R5R6NC (= O) N (-R7) -, R5R6NS (= O) 2N (R7) -, C6-10 aryl, aryl (C6-10) - C (= O) -, C3-10 cycloalkyl, C4-8 cycloalkenyl, C3-6 heterocyclyl and (C3-6) heterocyclyl -C (= O) -; wherein said C1-10 alkyl, C2-10 alkenyl, C2-10 alkynyl, (C6-10) aryl (C1-6) alkyl, (C6-10) aryl -C (= O) -C 1-6 alkyl, cycloalkyl (C3-10) -C1-6 alkyl, cycloalkenyl (C4-8) -alkyl (C1-6), heterocyclyl (C3-6) -alkyl (C1-6), heterocyclyl (C3-6) -C ( = O) -C1-6 alkyl, hydrocarbonylamino (C1-10), aryl C6-10, aryl (C6-10) -C (= O) -, C3-10 cycloalkyl, C4-8 cycloalkenyl, C3-6 heterocyclyl heterocyclyl (C3-6) -C (= O) - used in the definition of R1 are optionally substituted with one or more groups selected from halogen, cyano, nitro, methoxy, ethoxy, methyl, ethyl, hydroxy and -NR5R6; R2 is selected from C1-10 alkyl, C2-10 alkenyl, C2-10 alkynyl, C3-10 cycloalkyl, (C3-10) cycloalkyl (C1-6) alkyl, (C4-8) cycloalkenyl (C1-6 alkyl) ), (C3-6) heterocycloalkyl (C1-6) alkyl, C4-8 cycloalkenyl, C3-5 heteroaryl, C6-10 aryl and C3-6 heterocycloalkyl, wherein said C1-10 alkyl, C2-10 alkenyl , C2-10 alkynyl, C3-8 cycloalkyl, (C3-8) cycloalkyl (C1-6) alkyl, (C4-8) cycloalkenyl-(C1-6) alkyl, (C3-6) heterocycloalkyl (C1-) alkyl 6), C4-8 cycloalkenyl, C3-5 heteroaryl, C6-10 aryl or C3-6 heterocycloalkyl, used in the definition of R2 are optionally substituted with one or more groups selected from halogen, cyano, nitro, methoxy, ethoxy, methyl , ethyl, hydroxy and -NR5R6; where R5, R6 and R7 are independently selected from -H, C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl and a divalent C1-6 group which together with another divalent R5, R6 or R7 forms a portion of a ring ; R3 is selected from -H, C1-10 alkyl, C2-10 alkenyl, C2-10 alkynyl, C3-10 cycloalkyl, (C3-10) cycloalkyl (C1-6) alkyl, (C4-8) cycloalkenyl ( C1-6), C3-6 heterocycloalkyl, or a group of formulas (2), optionally substituted with one or more groups selected from C1-6 alkyl, halogen, amino and C1-6 alkoxy; each of R8 and R9 is independently selected from -H, C1-10 alkyl, C2-10 alkenyl, C2-10 alkynyl, C3-10 cycloalkyl, (C3-10) cycloalkyl (C1-6) alkyl, C3- heterocyclyl 6, C6-10 aryl, (C3-6) heterocyclyl (C1-6) alkyl, (C6-10) aryl (C1-6) alkyl and a divalent C1-6 group which together with another divalent group selected from R8 and R9 forms a portion of a ring, wherein said C1-10 alkyl, C2-10 alkenyl, C2-10 alkynyl, C3-10 cycloalkyl, (C3-10) cycloalkyl (C1-6) alkyl, C3-6 heterocyclyl, C6-10 aryl, (C3-6) heterocyclyl (C1-6) alkyl, (C6-10) aryl (C1-6) alkyl or a divalent C1-6 group is optionally substituted with one or more groups selected from halogen , cyano, nitro, methoxy, ethoxy, methyl, ethyl, hydroxy and -NR5R6; and R4 is selected from -H, C1-10 alkyl, C2-10 alkenyl, C2-10 alkynyl, C3-10 cycloalkyl, (C3-10) cycloalkyl (C1-6) alkyl and (C4-8) cycloalkenyl (C1-6).
priorityDate 2003-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5798
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393705
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409283606

Total number of triples: 33.